Skip to content

Opening book details…

About this Medicine article

Outcomes for Asian patients with multiple myeloma receiving once- or twice-weekly carfilzomib-based therapy: a subgroup analysis of the randomized phase 3 ENDEAVOR and A.R.R.O.W. Trials by Dimopoulos, Meletios A.; Moreau, Philippe; Iida, Shinsuke; Huang, Shang-Yi; Takezako, Naoki; Chng, Wee Joo; Zahlten-Kumeli, Anita; Sersch, Martina A.; Li, Julia; Huang, Mei; Lee, Jae Hoon is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Dimopoulos, Meletios A.; Moreau, Philippe; Iida, Shinsuke; Huang, Shang-Yi; Takezako, Naoki; Chng, Wee Joo; Zahlten-Kumeli, Anita; Sersch, Martina A.; Li, Julia; Huang, Mei; Lee, Jae Hoon
Publisher
Carden Jennings Publishing; Springer-Verlag; Springer Japan; Springer Science and Business Media LLC (ISSN 0925-5710)
Published
2019
Language
EN
Field
Medicine (Health Sciences)

More by Dimopoulos, Meletios A.; Moreau, Philippe; Iida, Shinsuke; Huang, Shang-Yi; Takezako, Naoki; Chng, Wee Joo; Zahlten-Kumeli, Anita; Sersch, Martina A.; Li, Julia; Huang, Mei; Lee, Jae Hoon

Browse all works by Dimopoulos, Meletios A.; Moreau, Philippe; Iida, Shinsuke; Huang, Shang-Yi; Takezako, Naoki; Chng, Wee Joo; Zahlten-Kumeli, Anita; Sersch, Martina A.; Li, Julia; Huang, Mei; Lee, Jae Hoon